White Paper - Transforming R&D Productivity by Re-defining Success in Clinical Trial Enrollment
It may come as a surprise to many pharmaceutical industry experts that the largest portion of an R&D sponsor's investment and the biggest driver of trial budgets is patient enrollment at 32% of trial costs . To those who are already aware of this, it may still be surprising that innovation required to improve this disproportionate budget allocation is already available.
For more information about Acurian, visit http://www.acurian.com/.
